Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis

NJ Brown - Nature Reviews Nephrology, 2013 - nature.com
The steroid hormone aldosterone regulates sodium and potassium homeostasis.
Aldosterone and activation of the mineralocorticoid receptor also causes inflammation and …

Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology

F Jaisser, N Farman - Pharmacological reviews, 2016 - ASPET
The mineralocorticoid receptor (MR) and its ligand aldosterone are the principal modulators
of hormone-regulated renal sodium reabsorption. In addition to the kidney, there are several …

Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update

MK Arora, UK Singh - Vascular pharmacology, 2013 - Elsevier
Diabetes mellitus is known to trigger retinopathy, neuropathy and nephropathy. Diabetic
nephropathy, a long-term major microvascular complication of uncontrolled hyperglycemia …

Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases

J Bauersachs, F Jaisser, R Toto - Hypertension, 2015 - Am Heart Assoc
Direct deleterious effects of aldosterone in the heart include development of myocardial
hypertrophy, ventricular remodeling, proarrhythmogenic effects, myocardial ischemia …

Aldosterone: effects on the kidney and cardiovascular system

M Briet, EL Schiffrin - Nature Reviews Nephrology, 2010 - nature.com
Aldosterone, a steroid hormone with mineralocorticoid activity, is mainly recognized for its
action on sodium reabsorption in the distal nephron of the kidney, which is mediated by the …

Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease

HM Siragy, RM Carey - American journal of nephrology, 2010 - karger.com
The existence of local or tissue-based renin-angiotensin-aldosterone systems (RAAS) is
well documented and has been implicated as a key player in the pathogenesis of …

Endothelial dysfunction as a potential contributor in diabetic nephropathy

T Nakagawa, K Tanabe, BP Croker… - Nature Reviews …, 2011 - nature.com
The mechanisms that drive the development of diabetic nephropathy remain undetermined.
Only 30–40% of patients with diabetes mellitus develop overt nephropathy, which suggests …

Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: an overview

A Odermatt, DV Kratschmar - Molecular and cellular endocrinology, 2012 - Elsevier
In the last decade significant progress has been made in the understanding of
mineralocorticoid receptor (MR) function and its implications for physiology and disease …

Mineralocorticoid receptor antagonists in diabetic kidney disease

D Kawanami, Y Takashi, Y Muta, N Oda… - Frontiers in …, 2021 - frontiersin.org
Diabetic kidney disease (DKD) is a major cause of end-stage kidney disease (ESKD)
worldwide. Mineralocorticoid receptor (MR) plays an important role in the development of …

Update on RAAS modulation for the treatment of diabetic cardiovascular disease

S Bernardi, A Michelli, G Zuolo… - Journal of diabetes …, 2016 - Wiley Online Library
Since the advent of insulin, the improvements in diabetes detection and the therapies to treat
hyperglycemia have reduced the mortality of acute metabolic emergencies, such that today …